China Daratumumab injection Manufacturers Factory Suppliers
-
Daratumumab Injection - Multiple Myeloma (CD-38 Mab), CAS No.: 945721-28-8
Hangzhou Jiuyuan is a top-biotech joint venture specializing in the research, development, manufacture, and marketing of pharmaceuticals based on gene engineering and biochemical technology since
-
Palonosetron Hydrochloride Injection– Anti-emesis After Chemotherapy Or Radiotherapy, CAS No.: 135729-62-3, Palonosetron Hydrochloride Injection 0.25mg/5ml, 0.075mg/1.5ml
Generic Name: Palonosetron Hydrochloride injection. The quality and efficacy consistency of generic drugs were evaluated.. The second generation 5-HT3 receptor antagonist, super antagonistic, long -
-
RhIL-11 Injection(Oprelvekin), CAS No.: 145941-26-0, (Recombinant Human Interleukin-11) – A Drug To Increase Platelet Count, RhIL-11 Injection Lyophilized Powder (vial): 0.75mg/vial, 1.5mg/vial, 3mg/vial
Generic Name: Oprelvekin. Trade Name: JIJUFEN. Chemical Name: Human Interleukin-11 for Injection. The only drug approved by FDA for prevention and treatment of Chemoradiotherapy-induced
-
RhG-CSF Injection(Filgrastim) (Recombinant Human Granulocyte Colony-Stimulating Factor) – A Drug To Increase White Blood Cell Count, CAS No.: 121181-53-1
Generic Name: Filgrastim. Trade Name: JILIFEN. Chemical Name: Human Granulocyte-Colony Stimulating Factor (hG-CSF) Injection.
-
Fulvestrant– An Anti-cancer Drug ,CAS No.: 129453-61-8
Fulvestrant is a prescription medicine used to treat advanced breast cancer or breast cancer that has spread to other parts of the body (metastatic).
-
Daratumumab (with Recombinant Human Hyaluronidase)injection, CAS No.: 945721-28-8
Name: Daratumumab (with recombinant human hyaluronidase). CD38 inhibitor with recombinant human hyaluronidase. INDICATIONS: Multiple myeloma
-
SIRPα- Specific Monoclonal Antibody
Name: SIRPα. - Specific monoclonal antibody. INDICATIONS: Solid tumors
-
Romosozumab Injection - Osteoporosis, CAS: 909395-70-6
Name: Romosozumab injection . Sclerostin inhibitor. INDICATIONS: Osteoporosis
-
Amylin Analog , CAS No.: 138398-61-5
Name: Amylin analog. Peptide . Indication: Obesity and overweight
-
Fulvestrant Injection– An Anti-cancer Drug,CAS No.: 129453-61-8, Bulk and Injection (PFS): 250mg in 5ml
Fulvestrant is a prescription medicine used to treat advanced breast cancer or breast cancer that has spread to other parts of the body (metastatic).
-
PegFilgrastim Injection– A Long Lasting RhG-CSF, CAS No.: 208265-92-3,Bulk and Injection (PFS): 6mg in 0.6ml
Pegfilgrastim (pegfilgrastim) is a colony-stimulating factor, a man-made form of a protein that stimulates the growth of white blood cells, used to decrease the incidence of infection, by treating
-
Fosaprepitant Dimeglumine Injection, CAS No.: 265121-04-8,Bulk and Injection(vial)150mg/5ml
Fosaprepitant dimeglumine for injection is a sterile, lyophilized formulation containing fosaprepitant dimeglumine, a prodrug of aprepitant, a substance P/neurokinin-1 (NK1) receptor antagonist
Daratumumab and hyaluronidase-fihj injection comes as a solution (liquid) to be injected subcutaneously (just under the skin) into the abdomen (stomach) over 3 to 5 minutes. The...
Mar 01, 2022 · Daratumumab injection is also used in combination with pomalidomide and dexamethasone to treat patients with multiple myeloma who have received at least two...
Apr 22, 2022 · Darzalex must be diluted with 0.9% Sodium Chloride Injection, USP [see DOSAGE AND ADMINISTRATION ]. Each Darzalex single-dose 20 mL vial contains 400 mg...
Daratumumab injection is used alone or in combination with other medications to treat multiple myeloma (a type of cancer of the bone marrow) in newly diagnosed people and in people who...
First dose of the every-2-week dosing schedule is given at Week 9. First dose of the every-2-week dosing schedule is given at Week 1 upon re-initiation of treatment following autologous stem...
Nov 06, 2020 · Daratumumab is given as an infusion into a vein. A healthcare provider will give you this injection. Daratumumab is usually given every 1 to 3 weeks during the first several...
